Clinical Trial Update: Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating tisotumab vedotin as a monotherapy and in combination with other cancer agents in cervical cancer, with the study status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tisotumab Vedotin (tisotumab vedotin)

Snippet

Sponsor: Seagen, a wholly owned subsidiary of Pfizer | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: TERMINATED